Genetic Technologies (GENE) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Genetic Technologies Ltd has fully complied with the ASX Corporate Governance Council’s recommendations for the reporting period ending June 30, 2024, as detailed in their corporate governance statement. This information, along with their board charter and diversity policy, is available on their website for investor review. The company’s adherence to these governance standards is current as of September 30, 2024, and has been formally approved by the board.
For further insights into GENE stock, check out TipRanks’ Stock Analysis page.
